• 407-549-3929
  • info@gapsos.com
Latest Peer Review Articles by our Clinical and Medical Team at Global Allied Pharmaceuticals

IMMUNOTHERAPY AND PANCREATIC CANCER

Integrative Gastroenterology and Hepatology Immunotherapy and Pancreatic Cancer Allen T* , Shoja G and Court NB Global Allied Pharmaceuticals, Center for Excellence in Research and Development, USA * Correspondence: Timothy Allen, Global Allied Pharmaceuticals, Center for Excellence in Research and […]

Read More

IMMUNOTHERAPY AND MENINGIOMA

Immunotherapy and Meningioma Timothy Allen*, Ariel Sheikkhon, Shoja E Razavi, Naveed Basha Court Global Allied Pharmaceuticals, Center for Excellence in Research and Development, USA. timallenmed69@gmail.com *Corresponding Author: Timothy Allen, Global Allied Pharmaceuticals, Center for Excellence in Research and Development, 160 […]

Read More

Immunotherapy and penis cancer

Abstract Penis cancer, a cancerous disease in which malignant cells appear in the tissues of the penis. It occurs in the uncircumcised older men. It is recognized by at least two independent carcinogenic routes: virus and non-virus induced. The penis […]

Read More

Competitive Treatment in Diffuse Large B-cell lymphoma (DLBCL) and the Future SOC for the First Line Therapy

Download Abstract Diffuse large B-cell lymphoma (DLBCL) in the most common type of non-Hodgkin’s lymphoma (NHL) in developed world, so far and approximately 60,000 new non-Hodgkin lymphoma (NHL) cases and 20,000 deaths have been estimated in the United States for […]

Read More

Frontline Treatment in Diffuse Large B-Cell Lymphoma(DLBCL) and the Futuristic Alternate Standard of Care for the First Line Therapy

Download Abstract Diffuse large B cell lymphoma (DLBCL) in the most common type of non-Hodgkin’s lymphoma (NHL) in developed world, so far and approximately 60,000 new non-Hodgkin lymphoma (NHL) cases and 20,000 deaths have been estimated in the United States […]

Read More

Malignant melanoma

Abstract Download Worldwide incidence of malignant melanoma has been constantly increasing during the last years. Surgical excision is effective when primary tumors are thin with thickness of less than 1milli meter and there is no evidence of metastases. At later […]

Read More

Gastrointestinal Events Associated with Ipilimumab and combination therapies

Download Gastrointestinal Events Associated with Ipilimumab, Pazopanib, Anti PD1- Antibody and Their Management: Single and Combination Therapies Timothy Allen, MD, Ph.D1*, Giridhar M.N.V, MD,MBA1*, Ghazaleh Shoja E Razavi MD2 1Global Allied Pharmaceutical, Center for Excellence in Research & Development, USA. […]

Read More

PROTEASOME INHIBITION IN LYMPHOPROLIFERATIVE DISORDER.

Abstract Download Proteasomes are multi-subunit protein complexes, which present numerous targets for therapeutic interference. The most commonly used proteasome is 26S proteasome, which contains one 20S proteolytic core subunit and two 19S regulatory cap subunits. There are three different types […]

Read More

Toxicities Associated with Antibody Drug Conjugates

Abstract Download Conventional chemotherapeutic agents, in the treatment of several cancers, lack specificity, resulting in toxicities to normal tissues and poor therapeutic index. Antibody-based immunoconjugates are specifically targeted monoclonal antibodies that deliver the cytotoxic agent to the target cell. When […]

Read More

Mechanisms of drug resistance in Glioblastoma Multiforme.

Abstract Download Glioblastoma multiforme (GBM) is a group of low-grade as well as high-grade brain tumors that originate from the glia;neuroglial cells and are the most common and crucial brain tumor, specially in adults. The main causes are deemed to […]

Read More
Page 1 of 7
1 2 3 7
Stay in Touch with us by ...

Subscribe to our Newsletter